INAB (IN8bio) Accounts Payable: $0.45 Mil (As of Mar. 2026)


INAB IN8bio Inc INAB
28 GF Score
Price $1.43
View Full Analysis

What is IN8bio Accounts Payable?

IN8bio INAB +1.41% 28 Accounts Payable is $0.45 Mil as of Mar. 2026. GuruFocus rates INAB with a GF Score™ of 28/100.

IN8bio's Accounts Payable for the quarter that ended in Mar. 2026 was $0.45 Mil.

IN8bio's quarterly Accounts Payable increased from Sep. 2025 ($0.20 Mil) to Dec. 2025 ($0.31 Mil) and increased from Dec. 2025 ($0.31 Mil) to Mar. 2026 ($0.45 Mil).

IN8bio's annual Accounts Payable declined from Dec. 2023 ($0.92 Mil) to Dec. 2024 ($0.39 Mil) and declined from Dec. 2024 ($0.39 Mil) to Dec. 2025 ($0.31 Mil).

IN8bio Accounts Payable Historical Data

* Premium members only.

The historical data trend for IN8bio's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IN8bio Accounts Payable Chart

IN8bio Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial 0.40 2.09 0.92 0.39 0.31

IN8bio Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.58 0.38 0.20 0.31 0.45
INAB
28GF Score
IN8bio Inc INAB
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IN8bio Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $0.45 Mil mean?
IN8bio (INAB) has a Accounts Payable of $0.45 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on IN8bio and its competitors.
Is IN8bio's Accounts Payable too high?
IN8bio's current Accounts Payable is $0.45 Mil. Overall, IN8bio has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does IN8bio's Accounts Payable compare to GDTC and LEXX?
IN8bio's Accounts Payable of $0.45 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on IN8bio and its competitors. IN8bio's current Accounts Payable is $0.45 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IN8bio stock overvalued right now?
IN8bio (INAB) has a current Accounts Payable of $0.45 Mil. The current Accounts Payable is $0.45 Mil. IN8bio's overall GF Score™ is 28/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For IN8bio (INAB), the current Accounts Payable is $0.45 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

IN8bio Business Description

Address 350 5th Avenue, Suite 5330, New York, NY, USA, 10118
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell engagers (TCEs) for cancer and autoimmune diseases. Gamma-delta T cells are a specialized population of T cells that possess properties. It has conducted two primary investigator-sponsored Phase 1 clinical trials evaluating its gamma-delta T cell technologies in cancer patients, which have both completed primary enrollment. INB-100 is assessing its DeltEx Allogeneic (Allo) gamma-delta T cell therapy in adult patients with high-risk leukemias undergoing haploidentical stem cell transplantation (HSCT). It operates in a single segment.
28GF Score

Get the complete analysis for INAB

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.43
Price